Le Travenues Technology Limited Monitoring Agency Reports for Quarter Ended March 31, 2026
Le Travenues Technology Limited has released the Monitoring Agency reports for the quarter ended March 31, 2026. These reports cover the…
Aarti Pharmalabs Board Meeting Rescheduled to May 25, 2026
Aarti Pharmalabs has announced a change in the schedule for its upcoming board meeting. Originally planned for May 18, 2026, the meeting to…
Alembic Pharmaceuticals Limited USFDA Issues Establishment Inspection Report for Karakhadi Facility
Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the USFDA for its Injectable facility (F-III)…
HFCL Limited Investment in New Defence Manufacturing Facility in Andhra Pradesh
HFCL Limited has announced the establishment of a new defence manufacturing facility in the Sri Satya Sai District of Andhra Pradesh. With an…
IFB Industries Limited Registrar and Transfer Agent Amalgamation Update
IFB Industries Limited has announced that its Registrar and Transfer Agent (RTA), CB Management Services Private Limited, has successfully…
Titagarh Rail Systems Limited Statement of Utilization of Warrant Proceeds for Q4 FY2026
Titagarh Rail Systems Limited has confirmed the status of its warrant proceeds utilization for the quarter ending March 31, 2026. The company…
Titagarh Rail Systems Limited Monitoring Agency Report for Quarter Ending March 31, 2026
Titagarh Rail Systems Limited has released its Monitoring Agency Report for the quarter ended March 31, 2026. The report details the status of…
Canara Bank Robust Growth and Strategic Performance in FY 2025-26
Canara Bank has announced strong financial results for the fourth quarter and the full fiscal year 2025-26. The bank achieved a global…
Kirloskar Oil Engines Limited Board Approves Grant of 2.4 Lakh Employee Stock Options
Kirloskar Oil Engines Limited has announced the approval for the grant of 2,40,000 employee stock options under its existing incentive plan.…
Alembic Pharmaceuticals Receives USFDA Tentative Approval for Darolutamide Tablets
Alembic Pharmaceuticals has received USFDA tentative approval for its Darolutamide Tablets, 300 mg, a medication used to treat various forms…